Delivery Order SPE2DB20D2104-SPE2DB25F1273

Award Date 11/1/24
Potential Completion Date 11/4/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,156.56, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4565178283 - TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, and has an ultimate completion date of July 18, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award is for the delivery of TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,402.46 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 16, 2024. The contract has a completion date of December 17, 2024 and is a Firm Fixed Price Delivery Order. The contract is not associated with a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Timolol 0.5% Gel-Solution, a prescription eye medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $4,356.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product. The contract has a firm fixed price of $2,833.08 and a completion date of October 8, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor, and this delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that the company holds with the DLA Troop Support...
This federal contract award is a delivery order (SPE2DB23FU60L) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,525.25 firm fixed-price contract is for the delivery of 4,561,625,810 units of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract has a completion date of July 28, 2023 and was awarded on July 27, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award is a delivery order valued at $6,250.55 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Timolol 0.5% Gel-Solution, a pharmaceutical product used in the treatment of certain eye conditions. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award, valued at $1,362.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Timolol 0.5% Gel-Solution, a prescription eye drop, to support military healthcare programs. The contract has an ultimate completion date of November 6, 2024 and is a firm fixed-price arrangement. It is not designated as a set-aside contract,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Timolol 0.25% Gel-Solution, a medication used to treat glaucoma. The award has a ceiling value of $9,314.13 and a completion date of March 7, 2023. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,818.42, is for the delivery of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,295.24 and covers the delivery of a 5ml gel-solution of the medication Timolol 0.25%. The award does not have any set-aside designation, indicating it was an open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25F1273
    Delivery Order

This federal contract award, valued at $7,643.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TIMOLOL 0.5% GEL-SOLUTION 5ML, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 4, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/20/25, 2:02 PM